Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Incyte Corp (INCY)

Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,487,201
  • Shares Outstanding, K 193,570
  • Annual Sales, $ 4,241 M
  • Annual Income, $ 32,610 K
  • EBIT $ 175 M
  • EBITDA $ 264 M
  • 60-Month Beta 0.68
  • Price/Sales 2.96
  • Price/Cash Flow 117.01
  • Price/Book 3.42

Options Overview Details

View History
  • Implied Volatility 33.35% ( +0.75%)
  • Historical Volatility 28.35%
  • IV Percentile 44%
  • IV Rank 32.27%
  • IV High 63.71% on 03/11/25
  • IV Low 18.89% on 05/24/24
  • Put/Call Vol Ratio 0.10
  • Today's Volume 11
  • Volume Avg (30-Day) 413
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 15,000
  • Open Int (30-Day) 20,825

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 1.11
  • Number of Estimates 8
  • High Estimate 1.18
  • Low Estimate 1.05
  • Prior Year -2.03
  • Growth Rate Est. (year over year) +154.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.29 +11.15%
on 04/24/25
66.11 -3.68%
on 05/20/25
+5.68 (+9.79%)
since 04/23/25
3-Month
53.56 +18.89%
on 04/09/25
76.24 -16.47%
on 02/25/25
-8.43 (-11.69%)
since 02/21/25
52-Week
53.56 +18.89%
on 04/09/25
83.95 -24.15%
on 11/08/24
+6.23 (+10.84%)
since 05/23/24

Most Recent Stories

More News
Is Wall Street Bullish or Bearish on Incyte Stock?

Despite Incyte’s underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

BAC : 43.01 (-0.69%)
$SPX : 5,794.69 (-0.81%)
IBB : 120.16 (-1.04%)
INCY : 63.63 (-1.36%)
INCY Q1 Earnings & Revenues Beat Estimates on Higher Product Sales

Incyte Corporation INCY reported first-quarter 2025 adjusted earnings of $1.16 per share, which beat the Zacks Consensus Estimate of $1.01. The company had recorded adjusted earnings of 58 cents per share...

BAYRY : 6.9680 (+0.71%)
LLY : 712.50 (-0.38%)
INCY : 63.63 (-1.36%)
NVS : 112.63 (+0.12%)
3 Value Stocks Facing Headwinds

3 Value Stocks Facing Headwinds

CARS : 10.02 (-1.96%)
MTCH : 29.17 (-0.95%)
INCY : 63.63 (-1.36%)
3 Value Stocks Facing Headwinds

3 Value Stocks Facing Headwinds

CARS : 10.02 (-1.96%)
MTCH : 29.17 (-0.95%)
INCY : 63.63 (-1.36%)
Incyte (NASDAQ:INCY) Delivers Strong Q1 Numbers

Incyte (NASDAQ:INCY) Delivers Strong Q1 Numbers

INCY : 63.63 (-1.36%)
Incyte (NASDAQ:INCY) Delivers Strong Q1 Numbers

Incyte (NASDAQ:INCY) Delivers Strong Q1 Numbers

INCY : 63.63 (-1.36%)
Incyte: Q1 Earnings Snapshot

Incyte: Q1 Earnings Snapshot

INCY : 63.63 (-1.36%)
Incyte (INCY) Q1 Earnings Report Preview: What To Look For

Incyte (INCY) Q1 Earnings Report Preview: What To Look For

INCY : 63.63 (-1.36%)
ABBV : 182.27 (-0.15%)
GILD : 106.02 (-0.67%)
3 Cash-Heavy Stocks Skating on Thin Ice

3 Cash-Heavy Stocks Skating on Thin Ice

MOV : 16.66 (-1.77%)
INCY : 63.63 (-1.36%)
SONO : 9.74 (-2.21%)
Incyte Earnings Preview: What to Expect

Incyte is all set to release its fiscal first-quarter earnings later this month, and analysts project a high double-digit profit growth.

XLV : 129.72 (-0.64%)
$SPX : 5,794.69 (-0.81%)
INCY : 63.63 (-1.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2...

See More

Key Turning Points

3rd Resistance Point 66.49
2nd Resistance Point 65.91
1st Resistance Point 65.21
Last Price 63.63
1st Support Level 63.93
2nd Support Level 63.35
3rd Support Level 62.65

See More

52-Week High 83.95
Fibonacci 61.8% 72.34
Fibonacci 50% 68.75
Fibonacci 38.2% 65.17
Last Price 63.63
52-Week Low 53.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »